Premium
Biomea Fusion Inc (BMEA)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -1.57068062827 | 1.91 | 2.01 | 1.77 | 768164 | 1.89300865 | CS |
| 4 | -0.07 | -3.58974358974 | 1.95 | 2.0299 | 1.58 | 1617291 | 1.8232359 | CS |
| 12 | -0.44 | -18.9655172414 | 2.32 | 3.08 | 1.2905 | 2550411 | 2.23355299 | CS |
| 26 | -2.04 | -52.0408163265 | 3.92 | 4.59 | 1.2905 | 1532453 | 2.33756852 | CS |
| 52 | -3.42 | -64.5283018868 | 5.3 | 13.07 | 1.2905 | 1168879 | 4.04159929 | CS |
| 156 | -10.53 | -84.850926672 | 12.41 | 43.69 | 1.2905 | 873032 | 11.25472464 | CS |
| 260 | -18.12 | -90.6 | 20 | 43.69 | 1.2905 | 661209 | 11.200469 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
